Use of Hepatitis C Virus Antibody-Positive Donor Livers in Hepatitis C Nonviremic Liver Transplant Recipients
Given the shortage of available liver grafts, transplantation (LTx) of hepatitis C virus antibody-positive, nucleic acid test-negative (HCV Ab+/NAT-) livers into nonviremic HCV recipients can expand the donor pool. Having previously described the sentinel experience of HCV Ab+/NAT- allografts in nonviremic recipients, we report the growth and extended follow-up of this program for 55 patients compared with recipients of Public Health Services (PHS) increased-risk donor HCV Ab-/NAT- allografts.
Source: Journal of the American College of Surgeons - Category: Surgery Authors: Keith Luckett, Tiffany E. Kaiser, Khurram Bari, Kamran Safdar, Michael R. Schoech, Senu Apewokin, Tayyab S. Diwan, Madison C. Cuffy, Nadeem Anwar, Shimul A. Shah Tags: Southern surgical association article Source Type: research
More News: Bone Graft | Hepatitis | Hepatitis C | International Medicine & Public Health | Liver | Liver Transplant | Transplant Surgery | Transplants | Urology & Nephrology